Pudumjee Paper Products Ltd has announced its quarterly results for Q3FY26 and made key leadership appointments during its Board meeting held on January 31, 2026. The company released its Statement of Standalone Unaudited Financial Results for the quarter and nine months ended December 31, 2025.

Financial Results Announcement

The Board of Directors took on record the Statement of Standalone Unaudited Financial Results for the quarter and nine months ended December 31, 2025. The results were announced in compliance with regulatory requirements under Regulation 33.

Executive Leadership Re-appointment

The company announced the re-appointment of Dr. Ashok Kumar as Executive Director based on the recommendation of the Nomination and Remuneration Committee. This appointment demonstrates the company's confidence in his leadership and expertise.

Director Profile and Qualifications

Dr. Ashok Kumar brings extensive experience to his role as Executive Director. His educational background and industry expertise position him well for continued leadership at the company.

Professional Background:

• M.E. (Chemical) degree holder
• Ph.D. (Pulp Processing)
• Over four decades of experience in the Paper Industry
• Wide and varied industry experience

Regulatory Compliance

The company has fulfilled its obligations under SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The re-appointment information was provided in accordance with SEBI Master Circular No.: SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, read with Regulation 30 - Para A of Part A of Schedule III.

Dr. Ashok Kumar is not debarred from holding the office of Director by virtue of any SEBI order or any other authority, as confirmed in the company's disclosure. The Board meeting commenced at 1:20 p.m. and concluded at 2:00 p.m. on January 31, 2026.

Pudumjee Paper Products has announced a scheduled board meeting to review its third-quarter financial performance for fiscal year 2026. The company's Board of Directors will convene on Saturday, January 31, 2026, to consider and approve crucial financial documents for the reporting period.

Board Meeting Details

The upcoming board meeting will focus on comprehensive financial review and approval processes. The directors will examine the company's unaudited financial results along with the Limited Review Report for both the quarter and nine months ended December 31, 2025.

Trading Window Restrictions

In strict compliance with regulatory requirements, the company has implemented comprehensive trading restrictions. The trading window for dealing in securities has been closed for all designated persons and their immediate relatives, ensuring adherence to insider trading regulations.

Regulatory Compliance Framework

The company's approach demonstrates robust adherence to securities market regulations. The trading window closure aligns with provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Insider Trading Policy. This comprehensive restriction period extends from January 1, 2026, through February 2, 2026, covering both the pre-announcement period and 48 hours following the financial results declaration.

The announcement was communicated to both major stock exchanges where the company's shares are listed, ensuring transparent disclosure to all market participants and regulatory authorities.